These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 19875355

  • 21. Renal function after percutaneous coronary interventions depending on the type of hydration.
    Jarocka IT, Bachórzewska-Gajewska H, Kobus G, Czaban S, Małyszko J, Dobrzycki S.
    Adv Med Sci; 2013; 58(2):369-75. PubMed ID: 24285128
    [Abstract] [Full Text] [Related]

  • 22. Variation of serum and urinary neutrophil gelatinase associated lipocalin (NGAL) after strenuous physical exercise.
    Lippi G, Sanchis-Gomar F, Salvagno GL, Aloe R, Schena F, Guidi GC.
    Clin Chem Lab Med; 2012 Feb 14; 50(9):1585-9. PubMed ID: 22962218
    [Abstract] [Full Text] [Related]

  • 23. Non-inferiority of creatinine excretion rate to urinary L-FABP and NGAL as predictors of early renal allograft function.
    Pajek J, Škoberne A, Šosterič K, Adlešič B, Leskošek B, Bučar Pajek M, Osredkar J, Lindič J.
    BMC Nephrol; 2014 Jul 16; 15():117. PubMed ID: 25027586
    [Abstract] [Full Text] [Related]

  • 24. Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention.
    Liu XL, Wang ZJ, Yang Q, Yu M, Shen H, Nie B, Han HY, Gao F, Zhou YJ.
    Chin Med J (Engl); 2012 Mar 16; 125(6):1051-6. PubMed ID: 22613530
    [Abstract] [Full Text] [Related]

  • 25. Effect of a single intravenous immunoglobulin infusion on neutrophil gelatinase-associated lipocalin levels in proteinuric patients with normal renal function.
    Bolignano D, Coppolino G, Aloisi C, Romeo A, Nicocia G, Buemi M.
    J Investig Med; 2008 Dec 16; 56(8):997-1003. PubMed ID: 18955901
    [Abstract] [Full Text] [Related]

  • 26. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H, Shin N, Shin MJ, Yang BY, Kim IY, Song SH, Lee DW, Lee SB, Kwak IS, Seong EY.
    Korean J Intern Med; 2015 May 16; 30(3):354-61. PubMed ID: 25995666
    [Abstract] [Full Text] [Related]

  • 27. Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma.
    Papassotiriou GP, Kastritis E, Gkotzamanidou M, Christoulas D, Eleutherakis-Papaiakovou E, Migkou M, Gavriatopoulou M, Roussou M, Margeli A, Papassotiriou I, Dimopoulos MA, Terpos E.
    Clin Lymphoma Myeloma Leuk; 2016 Jan 16; 16(1):29-35. PubMed ID: 26632077
    [Abstract] [Full Text] [Related]

  • 28. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study.
    Lebkowska U, Malyszko J, Lebkowska A, Koc-Zorawska E, Lebkowski W, Malyszko JS, Kowalewski R, Gacko M.
    Transplant Proc; 2009 Jan 16; 41(1):154-7. PubMed ID: 19249501
    [Abstract] [Full Text] [Related]

  • 29. Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP.
    Parmaksız G, Noyan A, Dursun H, İnce E, Anarat R, Cengiz N.
    Pediatr Nephrol; 2016 Jan 16; 31(1):97-103. PubMed ID: 26324091
    [Abstract] [Full Text] [Related]

  • 30. Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.
    Chou KM, Lee CC, Chen CH, Sun CY.
    PLoS One; 2013 Jan 16; 8(1):e54863. PubMed ID: 23349979
    [Abstract] [Full Text] [Related]

  • 31. Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases.
    Nishida M, Kawakatsu H, Okumura Y, Hamaoka K.
    Pediatr Int; 2010 Aug 16; 52(4):563-8. PubMed ID: 20059722
    [Abstract] [Full Text] [Related]

  • 32. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography.
    Shaker OG, El-Shehaby A, El-Khatib M.
    Angiology; 2010 Nov 16; 61(8):731-6. PubMed ID: 20529972
    [Abstract] [Full Text] [Related]

  • 33. Liver fatty-acid-binding protein in heart and kidney allograft recipients in relation to kidney function.
    Przybylowski P, Koc-Zorawska E, Malyszko JS, Kozlowska S, Mysliwiec M, Malyszko J.
    Transplant Proc; 2011 Oct 16; 43(8):3064-7. PubMed ID: 21996226
    [Abstract] [Full Text] [Related]

  • 34. Neutrophil gelatinase-associated lipocalin as a predictor of complications and mortality in patients undergoing non-cardiac major surgery.
    Shavit L, Dolgoker I, Ivgi H, Assous M, Slotki I.
    Kidney Blood Press Res; 2011 Oct 16; 34(2):116-24. PubMed ID: 21311195
    [Abstract] [Full Text] [Related]

  • 35. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass.
    Tuladhar SM, Püntmann VO, Soni M, Punjabi PP, Bogle RG.
    J Cardiovasc Pharmacol; 2009 Mar 16; 53(3):261-6. PubMed ID: 19247188
    [Abstract] [Full Text] [Related]

  • 36. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Alharazy SM, Kong N, Saidin R, Gafor AH, Maskon O, Mohd M, Zakaria SZ.
    Angiology; 2014 May 16; 65(5):436-42. PubMed ID: 23580616
    [Abstract] [Full Text] [Related]

  • 37. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease.
    Poniatowski B, Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Dobrzycki S.
    Kidney Blood Press Res; 2009 May 16; 32(2):77-80. PubMed ID: 19287180
    [Abstract] [Full Text] [Related]

  • 38. Neutrophil gelatinase-associated lipocalin is a sensitive biomarker for the early diagnosis of acute rejection after living-donor kidney transplantation.
    Kohei J, Ishida H, Tanabe K, Tsuchiya K, Nitta K.
    Int Urol Nephrol; 2013 Aug 16; 45(4):1159-67. PubMed ID: 23161375
    [Abstract] [Full Text] [Related]

  • 39. Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes.
    Xie Y, Xue W, Shao X, Che X, Xu W, Ni Z, Mou S.
    PLoS One; 2014 Aug 16; 9(11):e112865. PubMed ID: 25402279
    [Abstract] [Full Text] [Related]

  • 40. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
    Akrawinthawong K, Ricci J, Cannon L, Dixon S, Kupfer K, Stivers D, Alexander P, David S, McCullough PA.
    Ren Fail; 2015 Mar 16; 37(2):187-91. PubMed ID: 25519207
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.